XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2
Business Segments and Geographic Information
 9 Months Ended
Jun. 25, 2022
Segment Reporting [Abstract]  
Business Segments and Geographic Information Business Segments and Geographic InformationThe Company has four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, goodwill and intangible asset impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items. Each segment's operating results include its share of allocated corporate administrative expenses.
Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three and nine months ended June 25, 2022 and June 26, 2021. Segment information is as follows:

 Three Months EndedNine Months Ended
 June 25,
2022		June 26,
2021		June 25,
2022		June 26,
2021
Total revenues:
Diagnostics$560.1 $665.5 $2,497.6 $2,858.2 
Breast Health282.8 349.0 952.7 1,018.0 
GYN Surgical138.1 127.9 389.6 366.2 
Skeletal Health21.7 25.9 69.7 73.3 
$1,002.7 $1,168.3 $3,909.6 $4,315.7 
Income (loss) from operations:
Diagnostics$175.0 $260.1 $1,247.4 $1,745.1 
Breast Health32.0 81.0 163.1 235.1 
GYN Surgical60.1 18.2 92.4 60.5 
Skeletal Health(3.2)(0.7)(3.6)0.1 
$263.9 $358.6 $1,499.3 $2,040.8 
Depreciation and amortization:
Diagnostics$67.8 $63.9 $205.4 $179.4 
Breast Health16.9 13.6 45.5 39.7 
GYN Surgical24.7 23.2 72.1 69.5 
Skeletal Health0.2 0.2 0.5 0.5 
$109.6 $100.9 $323.5 $289.1 
Capital expenditures:
Diagnostics$19.8 $35.7 $77.3 $113.2 
Breast Health2.2 4.5 9.2 10.1 
GYN Surgical2.8 3.0 6.9 9.5 
Skeletal Health0.1 0.2 0.3 0.2 
Corporate0.8 — 1.9 1.0 
$25.7 $43.4 $95.6 $134.0 
 
June 25,
2022		September 25,
2021
Identifiable assets:
Diagnostics$3,029.8 $3,348.8 
Breast Health1,244.0 1,233.9 
GYN Surgical1,488.2 1,369.7 
Skeletal Health25.8 31.9 
Corporate3,569.6 2,935.6 
$9,357.4 $8,919.9 

The Company had no customers that represented greater than 10% of consolidated revenues during the three and nine months ended June 25, 2022 and June 26, 2021.
The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company’s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company’s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The “Rest of World” designation includes Canada, Latin America and the Middle East.

Revenues by geography as a percentage of total revenues were as follows:
 
 Three Months EndedNine Months Ended
 June 25,
2022		June 26,
2021		June 25,
2022		June 26,
2021
United States73.3 %64.2 %70.1 %68.4 %
Europe16.4 %24.7 %19.2 %22.3 %
Asia-Pacific7.1 %7.7 %7.7 %6.2 %
Rest of World3.2 %3.4 %3.0 %3.1 %
100.0 %100.0 %100.0 %100.0 %